New drug for hypertrophic cardiomyopathy wins special support in America
5th May 2016
Drug is designed to treat underlying cause of the disease.

5th May 2016
Drug is designed to treat underlying cause of the disease.

2nd May 2016
HFEA considers another new licence to help families with cardiomyopathy

25th April 2016
says new study published in the British Medical Journal.

20th April 2016
One study from America suggests it may be a growing problem.

18th April 2016
for children with heart failure, say researchers.

14th April 2016
but some improvement in exercise capacity, symptoms and quality of life seen.

13th April 2016
says study from Denmark.

12th April 2016
says study from the Netherlands.

11th April 2016
More monitoring of medication changes and wider access to cardiac rehabilitation in new standard.

7th April 2016
American heart organisations say.